Evaluation of Total Bile Acid and Aminotransferases in HIV/AIDS Patients with Coinfection of Hepatitis B and C Viruses
暂无分享,去创建一个
[1] S. Obi. The Effect of Co-infection of HIV and Hepatotropic Viruses on Selected Biochemical and Haematological Markers of Patients in Northeastern Nigeria , 2014 .
[2] B. Ibeh,et al. Biochemical and haematological changes in HIV subjects receiving winniecure antiretroviral drug in Nigeria , 2013, Journal of Biomedical Science.
[3] W. Worodria,et al. Overt diabetes mellitus among newly diagnosed Ugandan tuberculosis patients: a cross sectional study , 2013, BMC Infectious Diseases.
[4] J. Chilongola,et al. The evolution of haematological and biochemical indices in HIV patients during a six-month treatment period. , 2012, African health sciences.
[5] E. Ekong,et al. A survey of hepatitis B and C virus prevalence in human immunodeficiency virus positive patients in a tertiary health institution in North Eastern Nigeria , 2012 .
[6] E. Ugwu,et al. Coinfection with hepatitis B and C viruses among HIV positive pregnant women in Enugu south east, Nigeria. , 2012, Nigerian Journal of Medicine.
[7] E. Anteyi,et al. Hepatitis B and C virus co-infection in Nigerian patients with HIV infection. , 2009, Journal of infection in developing countries.
[8] I. Adewole,et al. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. , 2008, Annals of hepatology.
[9] D. Egah,et al. Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria. , 2007, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.
[10] M. Sulkowski. Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] R. Chung,et al. Alanine Aminotransferase Levels Predict Insulin Resistance in HIV Lipodystrophy , 2003, Journal of acquired immune deficiency syndromes.
[12] D. Vlahov,et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. , 2000, JAMA.
[13] M. Kaplan,et al. Evaluation of abnormal liver-enzyme results in asymptomatic patients. , 2000, The New England journal of medicine.
[14] J. Gill,et al. Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV infection , 2000, Immunological reviews.
[15] K. Byth,et al. Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease , 1996, Journal of gastroenterology and hepatology.